Prevalence and risk factors for pulmonary embolism in patients with suspected acute exacerbation of COPD: a multi-center study.


Journal

European journal of internal medicine
ISSN: 1879-0828
Titre abrégé: Eur J Intern Med
Pays: Netherlands
ID NLM: 9003220

Informations de publication

Date de publication:
10 2020
Historique:
received: 22 08 2019
revised: 01 05 2020
accepted: 04 05 2020
pubmed: 1 6 2020
medline: 16 2 2021
entrez: 1 6 2020
Statut: ppublish

Résumé

Pulmonary embolism (PE) prevalence in acute exacerbations of COPD is highly variable. To investigate the prevalence and risk factors of PE in patients hospitalized in Departments of Internal Medicine because of AECOPD and suspected PE we conducted a retrospective multicenter study in patients with an AECOPD undergoing chest angio-computed tomography (angio-CT) because of clinical suspect of PE. 1043 patients (mean age 75.8 years ± 9.7 years, 34.5 % women) were included; 132 patients had PE (mean prevalence 12.66%, 95% confidence interval 10.73, 14.77%).) confirmed by angio-CT and 54 patients died during hospitalization (5.18 %). At multivariate analysis, age, female gender, clinical signs and symptoms suggestive of deep vein thrombosis, hypertension, PaCO PE prevalence is not negligible in this setting. A number of risk factors may help clinicians in identification of patients at increased risk of PE.

Identifiants

pubmed: 32474052
pii: S0953-6205(20)30191-6
doi: 10.1016/j.ejim.2020.05.006
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-59

Informations de copyright

Copyright © 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflict of interest to declare.

Auteurs

Francesco Dentali (F)

Department of Medicine and Surgery, Insubria University, Varese, Italy. Electronic address: fdentali@libero.it.

Fulvio Pomero (F)

Department of Internal Medicine, S. Lazzaro Hospital, Alba, Cuneo Italy.

Pierpaolo Di Micco (PD)

Department of Internal Medicine and Emergency Room, Ospedale Buon Consiglio Fatebenefratelli, Naples, Italy.

Micaela La Regina (M)

Risk Management Unit, East Ligurian Hospital, La Spezia, ASL5 Liguria, La Spezia, Italy.

Federica Landini (F)

Department of Emergency Medicine, Azienda Ospedaliero-Universitaria, Parma, Italy.

Nicola Mumoli (N)

Department of Internal Medicine, Ospedale Fornaroli, Magenta, Milan, Italy.

Filippo Pieralli (F)

Medicina Interna e di Urgenza, Azienda Ospedaliera Universitaria 'Careggi', Firenze, Italy.

Matteo Giorgi-Pierfranceschi (M)

Internal Medicine Department, Istituti Ospedalieri, Cremona, Italy.

Roberta Re (R)

Department of Internal Medicine, Ospedale Maggiore della Carità, Novara, Italy.

Josè Vitale (J)

Department of Medicine and Surgery, Insubria University, Varese, Italy.

Leonardo M Fabbri (LM)

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Andrea Fontanella (A)

Department of Internal Medicine, Ospedale Fatebenefratelli, Napoli, Italy.

Dimitriy Arioli (D)

Internal Medicine, Centro Emostasi e Trombosi, Stroke Unit, Azienda Ospedaliera ASMN, Reggio Emilia, Italy.
Department of Medicine and Surgery, Insubria University, Varese, Italy; Department of Internal Medicine, S. Lazzaro Hospital, Alba, Cuneo Italy; Department of Internal Medicine and Emergency Room, Ospedale Buon Consiglio Fatebenefratelli, Naples, Italy; Risk Management Unit, East Ligurian Hospital, La Spezia, ASL5 Liguria, La Spezia, Italy; Department of Emergency Medicine, Azienda Ospedaliero-Universitaria, Parma, Italy; Department of Internal Medicine, Ospedale Fornaroli, Magenta, Milan, Italy; Medicina Interna e di Urgenza, Azienda Ospedaliera Universitaria 'Careggi', Firenze, Italy; Internal Medicine Department, Istituti Ospedalieri, Cremona, Italy; Department of Internal Medicine, Ospedale Maggiore della Carità, Novara, Italy; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy; Department of Internal Medicine, Ospedale Fatebenefratelli, Napoli, Italy; Internal Medicine, Centro Emostasi e Trombosi, Stroke Unit, Azienda Ospedaliera ASMN, Reggio Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH